Altamira Therapeutics (CYTO) Financials

$0.13

$0.01 (10.18%)

As on 17-Jan-2025 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0.2

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Cashflow (CHF Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-11.51	-8.68	-13.67	-4.84	-8.39	-13.23
Cash Flow from Investing Activities	--	--	-3.51	-2.31	-3.00	-1.82
Cash from Financing Activities	10.62	9.83	6.61	16.96	7.38	5.73
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS (CHF)	--	--	--	--	--	--
Cash EPS (CHF)	--	--	--	--	--	--
Adjusted Book Value (CHF)	--	--	--	--	--	--
Dividend per Share (CHF)	--	--	--	--	--	--
Cash Flow per Share (CHF)	--	--	--	--	--	--
Free Cash Flow per Share (CHF)	--	--	--	--	--	--

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-317.83	-469.67	-113.76	-70.30	-119.27	-176.20
ROE (%)	783.37	-1,208.66	-118.00	-71.91	-136.94	-1,545.80
ROA (%)	-103.88	-211.03	-87.74	-54.62	-69.43	-83.00
EBIT Margin (%)	--	-5,809.65	-10,632.28	-3,028.04	12,962.76	-865.25
Net Margin (%)	--	-8,680.31	-27,222.33	-4,699.91	11,842.68	-908.09
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-1.00	3.78	-0.63	4.12	-1.04	2.93
EBIT Growth (%)	59.05	-161.41	-28.56	27.22	33.73	55.16
Net Profit Growth (%)	72.60	-52.55	-112.07	-23.65	42.31	52.90
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.02	-0.76	0.05	0.03	--	0.39
Short term debt to equity ratio	0.02	-0.72	0.01	0.03	--	0.39
Current Ratio	1.38	0.14	0.77	3.83	1.04	1.33
Quick Ratio	1.46	0.14	0.60	122.05	434.96	1.35
Interest Coverage	-7.04	-19.47	-35.81	-39.09	-253.57	-10.24

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	2.14	34.04	46.35	-598.75	25.31
Asset Turnover	--	0.02	0.00	0.01	-0.01	0.09
Receivable days	--	16.89	293.33	435.60	-2,138.26	81.02
Inventory Days	--	107.62	-29,125.82	--	--	--
Payable days	--	1,051.38	347.77	--	--	--
Cash Conversion Cycle	--	-926.86	-29,180.26	--	--	--